Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Chronic Pain Market Forecast Highlighting Growth From $91.67 Billion To $127.39 Billion
The persistent discomfort sector has experienced substantial expansion lately, projecting a rise from $84.66 billion in 2025 to $91.67 billion in 2026, reflecting a compound annual growth rate of 8.3%. Factors contributing to this historical upward trend include the escalating occurrence of long-term illnesses, a greater number of neuropathic and musculoskeletal pain cases, enhanced accessibility to pharmaceutical treatments for pain management, heightened acknowledgment within the medical community regarding chronic pain conditions, and the proliferation of specialized pain treatment centers.
The chronic pain sector is poised for substantial expansion in the upcoming years, projecting a market value of $127.4 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.6%. This upsurge is anticipated due to a confluence of factors, including a heightened need for tailored pain management approaches, a greater acceptance of bioelectronic technologies, the proliferation of remote pain management services via telehealth, a growing emphasis on alternatives to opioid medications, and augmented funding for pain-related research. Key developments anticipated during this projection period encompass the wider embrace of integrated, multidisciplinary pain care frameworks, increased utilization of neuromodulation devices, a discernible shift towards pharmaceutical treatments that do not involve opioids, the broadening availability of self-managed pain relief solutions at home, and a more profound incorporation of digital health technologies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp
Chronic Pain Market Expansion Supported By Key Demand Factors
The expanding population of individuals enduring chronic pain is a significant factor anticipated to fuel the advancement of the chronic pain market. Chronic pain is characterized by persistent discomfort that extends beyond typical recovery timelines, often lasting over three months. This widespread occurrence of chronic pain directly stimulates market expansion, as the heightened need for proficient pain management strategies, encompassing both medications and therapeutic equipment, fosters an environment ripe for industry innovation and progress. Illustratively, data from the Australian Institute of Health and Welfare, a governmental body in Australia, revealed in June 2024 that approximately 4.0 million Australians, representing 16% of the population, dealt with back issues in 2022, and by 2023, these conditions constituted the third most substantial contributor to the overall disease burden in the nation, accounting for 4.3% of it. Furthermore, a February 2024 publication by the Institute for Health Metrics and Evaluation, an American research institute focused on public health, forecast global instances of neck pain to potentially hit 269 million by 2050, with estimates varying between 219 and 322 million. Consequently, the substantial number of people experiencing chronic pain is a key driver for the chronic pain market’s growth.
Chronic Pain Market Categorization By Product Type And Application
The chronic pain market covered in this report is segmented –
1) By Product: Drug, Devices
2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications
3) By End User: Hospitals, Clinics, Research Organization
Subsegments:
1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids
2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices
Chronic Pain Market Growth Trends Influencing Competitive Dynamics
In the realm of chronic pain management, leading entities are increasingly embracing strategic alliances to introduce collaborative savings initiatives. These strategic partnerships are characterized by entities capitalizing on complementary strengths and assets to foster shared prosperity and advancement. Illustratively, a notable collaboration occurred in August 2023 when MOBĒ, a digital health pioneer from the United States, joined forces with Override Health, another American healthcare firm. Through this alliance, their objective is to tackle the complexities of chronic pain treatment by implementing a shared savings model that synergizes their distinct capabilities. MOBE, functioning as a health outcomes enterprise, employs sophisticated healthcare data analytics to underpin its personalized, intensive one-on-one health coaching and medication oversight system. In parallel, Override contributes an all-encompassing program that incorporates virtual multidisciplinary care, coaching focused on neuroplasticity, and peer support networks, designed to guide individuals contending with chronic pain through the often-fragmented landscape of healthcare delivery.
Chronic Pain Market Company Landscape And Strategic Competition
Major companies operating in the chronic pain market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics
Access The Complete Chronic Pain Market Report:
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report
Chronic Pain Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the chronic pain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
